Patel Alpen B, Hinni Michael L, Pollei Taylor R, Hayden Richard E, Moore Eric J
Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic, 5777 East Mayo Blvd., Phoenix, AZ, 85054, USA.
Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, USA.
Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3585-91. doi: 10.1007/s00405-015-3540-x. Epub 2015 Feb 8.
Alert the reader to the complication of severe dysphagia following transoral laser microsurgery (TLM) or transoral robotic surgery (TORS) for bilateral simultaneous or synchronous tonsillar squamous cell carcinoma.
A case series of four patients treated at an academic tertiary center between 2008 and 2012 is presented; two treated with transoral laser microsurgery and two with transoral robotic surgery for biopsy-proven untreated bilateral primary squamous cell carcinoma. Main outcome measures included functional swallowing determined by the Functional Outcome Swallowing Scale. The incidence of significant postoperative complications was recorded.
Two patients had surgery for discontiguous involvement of bilateral palatine tonsils with squamous cell carcinoma, while two patients had surgery for bilateral tonsillar squamous cell carcinoma with unilateral extension into the base of tongue. Complete swallowing failure as characterized by the Functional Outcome Swallowing Scale was seen postoperatively in 3/4 patients who underwent TLM or TORS for bilateral simultaneous tonsillar carcinoma, while one patient was lost to follow-up.
Severe dysphagia in the setting of bilateral oropharyngectomy for simultaneous or synchronous tonsillar squamous cell carcinoma is rarely described but a significant concern. In an era with increased use of transoral surgery as de-escalation therapy, this unusual complication warrants consideration. We report that transoral bilateral pharyngectomy is quite harmful to near-term and intermediate-term swallowing outcomes. This paper serves to provide warning against primary surgical intervention in this setting, while demonstrating that non-surgical treatment may be the best viable option.
提醒读者注意经口激光显微手术(TLM)或经口机器人手术(TORS)治疗双侧同时性或同步性扁桃体鳞状细胞癌后出现严重吞咽困难的并发症。
介绍了2008年至2012年在一家学术三级中心接受治疗的4例患者的病例系列;2例接受经口激光显微手术治疗,2例接受经口机器人手术治疗,均为活检证实的未经治疗的双侧原发性鳞状细胞癌。主要结局指标包括通过功能性吞咽结果量表确定的功能性吞咽情况。记录术后严重并发症的发生率。
2例患者因双侧腭扁桃体鳞状细胞癌不连续受累而接受手术,2例患者因双侧扁桃体鳞状细胞癌单侧延伸至舌根而接受手术。在接受TLM或TORS治疗双侧同时性扁桃体癌的4例患者中,有3例术后出现以功能性吞咽结果量表为特征的完全吞咽功能衰竭,1例失访。
双侧口咽切除术治疗同时性或同步性扁桃体鳞状细胞癌时出现的严重吞咽困难很少被描述,但却是一个重要问题。在经口手术作为降阶梯治疗使用增加的时代,这种不寻常的并发症值得考虑。我们报告经口双侧咽切除术对近期和中期吞咽结果有很大危害。本文旨在对这种情况下的初次手术干预提出警示,同时表明非手术治疗可能是最佳可行选择。